Picture of Aethlon Medical logo

AEMD — Aethlon Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Aethlon Medical Inc reports results for the quarter ended in March - Earnings Summary

* Aethlon Medical Inc  AEMD.OQ  reported a quarterly
adjusted loss
of 10 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue rose 4,317.3% to $574.25 thousand from a year ago;
analysts expected zero. 
    * Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 10 cents​.
    * The mean earnings estimate of analysts had risen by
about 10.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aethlon Medical Inc shares had risen by 1.9% this
quarter and
gained 41.5% so far this year.
    * The company reported a quarterly loss of $2.47 million.
    * Wall Street's median 12-month price target for Aethlon
Medical
Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data June
28 at 10:11 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.13          -0.10          Beat
 Dec. 31 2022      -0.08          -0.12          Missed
 Sep. 30 2022      -0.21          -0.18          Beat
 Jun. 30 2022      -0.22          -0.19          Beat

Recent news on Aethlon Medical

See all news